Cargando…

A Deletion Mutation within the Ligand Binding Domain Is Responsible for Activation of Epidermal Growth Factor Receptor Gene in Human Brain Tumors

Two transplantable cell lines of human glioblastoma multiforme GL‐3 and GL‐5 carried an amplification and overexpression of structurally altered epidermal growth factor (EGF) receptor gene: the 140 kilodalton EGF receptors in these cases exhibited a constitutively expressed tyrosine kinase activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hitoshi, Ohba, Yoshito, Tamaoki, Norikazu, Shibuya, Masabumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918101/ https://www.ncbi.nlm.nih.gov/pubmed/2168866 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02644.x

Ejemplares similares

Alterations of Mouse Proto‐oncogenes in Sarcomas Induced after Transplantation of Human Tumors in Athymic Nude Mice
por: Yuasa, Yasuhito, et al.
Publicado: (1990)

Co‐amplification of c‐myc and c‐erbB‐2 Oncogenes in a Poorly Differentiated Human Gastric Cancer
por: Tsuchiya, Terumasa, et al.
Publicado: (1989)

Modeling the binding of diverse ligands within the Ah receptor ligand binding domain
por: Giani Tagliabue, Sara, et al.
Publicado: (2019)

Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains
por: Hajdu, Tímea, et al.
Publicado: (2020)

Characterization of the Extracellular Domain in Vascular Endothelial Growth Factor Receptor‐1 (Flt‐1 Tyrosine Kinase)
por: Tanaka, Keiji, et al.
Publicado: (1997)

Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain
por: Loeffler, Hannes H, et al.
Publicado: (2013)

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor.
por: Okamoto, S., et al.
Publicado: (1996)

Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
por: Isobe, Kazutoshi, et al.
Publicado: (2014)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

Large deletions in the cytoplasmic kinase domain of the epidermal growth factor receptor do not affect its laternal mobility
Publicado: (1986)

A role for the epidermal growth factor-like domain of P-selectin in ligand recognition and cell adhesion
Publicado: (1994)

Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2
por: Hsiao, Ku-chuan, et al.
Publicado: (2003)

Vascular Endothelial Growth Factor Receptor Family in Ascidians, Halocynthia roretzi (Sea Squirt). Its High Expression in Circulatory System-Containing Tissues
por: Samarghandian, Saeed, et al.
Publicado: (2013)

In vivo consequences of deleting EGF repeats 8–12 including the ligand binding domain of mouse Notch1
por: Ge, Changhui, et al.
Publicado: (2008)

ESR1 ligand binding domain mutations in hormone-resistant breast cancer
por: Toy, Weiyi, et al.
Publicado: (2013)

Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas
por: Dahse, R, et al.
Publicado: (2009)

Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer
por: Schrevel, Marlies, et al.
Publicado: (2017)

A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction
por: Reyer, Henry, et al.
Publicado: (2016)

Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling
por: Pascarelli, Stefano, et al.
Publicado: (2021)

Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations
por: Liu, Xiaorong, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain
por: Lee, Jeffrey C, et al.
Publicado: (2006)

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
por: Makki, Nader, et al.
Publicado: (2013)

Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia
por: SHIBUYA, Masabumi
Publicado: (2011)

VEGF-VEGFR Signals in Health and Disease
por: Shibuya, Masabumi
Publicado: (2014)

Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain
por: Di Liddo, Rosa, et al.
Publicado: (2022)

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
por: Yamaoka, Toshimitsu, et al.
Publicado: (2017)

Structure and ligand binding of the ADP-binding domain of the NAD(+) riboswitch
por: Huang, Lin, et al.
Publicado: (2020)

Structural Dynamics of the Cereblon Ligand Binding Domain
por: Hartmann, Marcus D., et al.
Publicado: (2015)

Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naïve patient: A report of three cases
por: YAMAGUCHI, FUMIHIRO, et al.
Publicado: (2014)

The Kinetics of the Hydrogen/Deuterium Exchange of Epidermal Growth Factor Receptor Ligands
por: Iloro, Ibon, et al.
Publicado: (2008)

Structure of the homodimeric androgen receptor ligand-binding domain
por: Nadal, Marta, et al.
Publicado: (2017)

Exploring Ligand Binding Domain Dynamics in the NRs Superfamily
por: D’Arrigo, Giulia, et al.
Publicado: (2022)

Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII
por: Mashayekhi, Amir, et al.
Publicado: (2018)

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm
por: Casolari, D. A., et al.
Publicado: (2017)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
por: Nishiya, Naoyuki, et al.
Publicado: (2019)

Functional Effects In Silico Prediction for Androgen Receptor Ligand-Binding Domain Novel I836S Mutation
por: Rayevsky, Alexey, et al.
Publicado: (2021)

Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer
por: Takeuchi, Shinji, et al.
Publicado: (2020)

The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding
por: Indurthi, Venkata S.K., et al.
Publicado: (2020)

Evolution of Epidermal Growth Factor (EGF)-like and Zona Pellucida Domains Containing Shell Matrix Proteins in Mollusks
por: Shimizu, Keisuke, et al.
Publicado: (2022)

Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
por: Osawa, Tsuyoshi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6ab50m92pc8u7knphehhgrds9g